NRX Pharmaceuticals Q4 EPS $(0.05) Beats $(0.07) Estimate

NRX Pharmaceuticals, Inc. - Common Stock +0.57%

NRX Pharmaceuticals, Inc. - Common Stock

NRXP

3.54

+0.57%

NRX Pharmaceuticals (NASDAQ: NRXP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 68.75 percent increase over losses of $(0.16) per share from the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via